Sadoff Investment Management LLC Abb Vie Inc. Transaction History

Sadoff Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $217,766 - $256,300	-2,823 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $7,784 - $9,601	100 Added 3.67%	2,823 $260,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $13,336 - $14,826	-150 Reduced 5.22%	2,723 $258,000
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $125,692 - $148,722	-1,400 Reduced 32.76%	2,873 $266,000
Q1 2018 Apr 26, 2018	SELL	$92.01 - $123.21 $220,824 - $295,704	-2,400 Reduced 35.97%	4,273 $404,000
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $597,633 - $655,355	6,673	6,673 $645,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Sadoff Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sadoff Investment Management LLC with notifications on news.